TTrialPathMatch Me to Trials
← Back to trials
RecruitingAdvanced CancerMetastatic Cancer

Longitudinal Screening for Financial Hardship to Improve Outcomes in Patients With Advanced Cancer

Eligible age

21+ yrs

Accepts

All genders

Locations

5 states

Healthy volunteers

No

See if you qualify for this study

Answer a few quick questions about your location and health. Takes about a minute.

Check my eligibility →

About this study

The study aims to determine whether monthly remote digital financial hardship screening among adults with advanced/metastatic cancer, undergoing outpatient systemic therapy with non-curative intent, improves patient-centered outcomes, including financial worry, health-related quality of life (HRQoL), symptom burden, patient-reported cancer treatment adherence, and exploratory outcomes of overall survival, patient-reported economic burden, patient-reported support received, patient-reported financial coping strategies, and health insurance literacy.

Sponsor: Alliance Foundation Trials, LLC.

You may qualify if…

  • 1. Minimum age of 21
  • 2. Understands English and/or Spanish
  • 3. Has a diagnosis of advanced/metastatic cancer
  • 4. Currently undergoing systemic therapy (enteral or parenteral) with non-curative intent
  • 5. Has been receiving treatment for at least 2 months
  • 6. Life expectancy of at least 6 months, in the opinion of the treating oncologist
  • 7. Cognitively able to give informed consent

You may not qualify if…

  • 1. Under the age of 21
  • 2. Does not understand English or Spanish
  • 3. Has cognitive deficits that would preclude understanding of consent form and/or questionnaires
  • 4. Undergoing treatment with curative intent (e.g., adjuvant chemotherapy for breast, lung, or ovarian cancer, primary curative therapy for testis cancer or lymphoma)
  • 5. Not undergoing systemic therapy (enteral or parenteral) with non-curative intent
  • 6. Receiving treatment for fewer than 2 months
  • 7. Life expectancy is less than 6 months, in the opinion of the treating oncologist

Where it's recruiting

Arizona

Phoenix

New Hampshire

Concord · Manchester

New York

New York

South Carolina

Spartanburg

Source: ClinicalTrials.gov · NCT06963723 · last updated 2026-05-12